Otsuka Pharmaceutical Company, Limited

Kouichi Ozaki

Yoshikazu Shimada

Tsutomu Fujiwara

Masato Horie

Sadahito Shin, Deceased

Yosuke Harada

Masami Nagata

Satoshi Takeda

Yoshikazu Tanakahaitsu 201 Shimada

The invention provides a pancreas-specific gene comprising a base sequence coding for the amino acid sequence shown under SEQ ID NO:1, which gene is effective particularly in the fields of study, diagnosis and treatment, among others, of pancreatic carcinoma.

TSA305 gene

Isolated DNA molecule encoding human TSC403

An isolated hTFIIIA gene having a nucleotide sequence coding for the amino acid sequence of SEQ ID NO:1, as disclosed, and in particular the hTFIIIA gene having the nucleotide sequence of SEQ ID NO:2. The gene can be used to express a corresponding hTFIIIA protein. The gene and protein serve as transcription regulating factors, and are useful in the diagnosis or identification of hereditary disease, such as cancer or other diseases resulting from abnormal transcriptional control and, further, in analyzing the mechanisms of action thereof.

hTFIIIA gene

Growing community of inventors

Tokushima, Japan

Kouichi Ozaki